Severe aplastic anemia in a patient with rheumatoid arthritis after introduction of etanercept
Central European Journal of Medicine, 07/16/2012
Horai Y et al. – A 73–year–old female, diagnosed with rheumatoid arthritis (RA), complicated with severe levels of joint destruction, started etanercept (ETN) because of high persistent RA disease activity. Although her articular symptoms dramatically improved, she developed marked pancytopenia after the introduction of ETN.